Portfolio discontinuation
Following a strategic review in 2023, Bactiguard’s BIP portfolio is currently being discontinued. For further information on the discontinuation process, please contact Peter Rådqvist, Global Sales Manager, Bactiguard.
Our technology prevents infections and increase patient safety.
Following a strategic review in 2023, Bactiguard’s BIP portfolio is currently being discontinued. For further information on the discontinuation process, please contact Peter Rådqvist, Global Sales Manager, Bactiguard.
BIP Foley Catheter is an indwelling urinary catheter with the unique Bactiguard technology, which reduces microbial adhesion. Fewer bacteria adhere to the catheter surface, reducing the risk of catheter associated urinary tract infection.
Designed to:
BIP CVC is a central venous catheter with the unique Bactiguard technology, which reduces microbial adhesion. Fewer bacteria adhere to the catheter surface, reducing the risk of catheter related bloodstream infection.
Designed to:
BIP ETT is an endotracheal tube with the unique Bactiguard technology, which reduces microbial adhesion. Fewer bacteria adhere to the tube surface, reducing the risk of VAP.
Designed to: